The 4th Meeting of Committee of Creditors of Kobo Biotech Limited was held on Monday,13th January,2025 at 03:45 p.m. at BKC Centre,31-E, Laxmi Industrial Estate, New Link Road, Andheri West, Mumbai 400053 through video conferencing.

pdf

Kobo Biotech Ltd.

13 Feb 2025

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Invitation of Resolution Plan

BSE India

The Form G was published on 15-10-2024.

pdf

Kobo Biotech Ltd.

13 Feb 2025

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of …

BSE India

The 3rd CoC meeting held on Thursday,21st November,2024 at 03:45 p.m. at BKC Centre , 31-E Laxmi Industrial Estate, New Link Road, Andheri (W),Mumbai -400 053.

pdf

Kobo Biotech Ltd.

11 Feb 2025

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Replacement of Interim Resolution Professional (IRP)

BSE India

The erstwhile RP Mr. Ravindra Chaturvedi has been appointed by the Government of India as a Technical Member of NCLT vide notification issued by the Ministry of Corporate of Affairs, S.O.132(E).By virtue of this appointment and in compliance with the applicable provisions of the law, he has withdrawn from all ongoing assignments with immediate effect and hence has submitted his resignation. Committee of Creditors has approved appointment of CA Namrata Randeri as his replacement and Hon''ble NCLT Hyderabad Bench vide order dated 17.01.2025 in IA(I.B.C)/85/HYD/2025 in C.P. (IB)/277/HYD/2023 in the matter of Kobo Biotech Limited has allowed the replacement and appointed Ms. Namrata Amol Randeri as the new Resolution Professional (RP)in the matter

pdf

Kobo Biotech Ltd.

20 Nov 2024

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of …

BSE India

3rd meeting of the Committee of Creditors (CoC) of Kobo Biotech Limited to be held on Thursday, 21st November, 2024 at 3.45 p.m. at 31E, BKC Center, Laxmi Industrial Estate, New Link Road, Andheri (W), Mumbai - 400053 through audio-visual mean.

pdf

Kobo Biotech Ltd.

05 Nov 2024, 07:45PM

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-List of Creditors

BSE India

The IRP / RP verified the Claims received from the creditors of the prepared the List of Creditors based on which the CoC has been constituted. The List of Creditors was uploaded on the IBBI Portal on 05.09.2024 and thereafter the List of Creditors was revised on 05.10.2024.

pdf

Kobo Biotech Ltd.

05 Nov 2024, 07:37PM

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Public Announcement

BSE India

In compliance with Sec.13 read with Sec. 15 of the IBC, 2016 and Regulation 6 of IBBI CIRP Regulations, 2016, the IRP published Form A on 17th August, 2024 in Business Standard - all India Edition (English newspaper), Lakshadweep - Mumbai Edition in Marathi language and Mana Telangana - in Telugu language and a corrigendum Notice was published on 23rd August, 2024 rectifying a clerical error in the Form A inviting claims from the creditors of the Corporate Debtor (the Company)

pdf

Kobo Biotech Ltd.

05 Nov 2024, 07:26PM

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Appointment of Interim Resolution Professional (IRP)

BSE India

The Hon''ble NCLT vide Order dated 13.08.2024 (Order received on 16.08.2024) appointed Mr. Ravindra Chaturvedi, having Registration No. IBBI/IPA-001/IP-P00792/2017-2018/11359, as the Interim Resolution Professional

pdf

Kobo Biotech Ltd.

05 Nov 2024, 07:14PM

2.29

0.44%

Company Update

Kobo Biotech Ltd-$ - 531541 - Corporate Insolvency Resolution Process (CIRP)-Initiation of Corporate Insolvency Resolution Process …

BSE India

JM Financial Asset Reconstruction Company (acting as trustee of JMFARC-KVB Iris II march 2016 - Trust), Financial Creditor, filed Application under Sec. 7 of the Insolvency and Bankruptcy Code read with Rule 4 of the Insolvency and Bankruptcy (Application to Adjudicating Authority) Rules 2016 to initiate the CIR process against the Company. The Hon''ble NCLT, Hyderabad Bench vide Order dated 13.08.2024 initiated the CIR process.

pdf

Is Avon Lifesciences Ltd. worth buying?

13 Votes:

Buy 76.92%

Sell 7.69%

Hold 15.38%